BACKGROUND: Ineffective clearance of Ehrlichia canis after doxycycline administration has been reported despite the fact that the recommended treatment for canine ehrlichiosis is doxycycline. The effectiveness of doxycycline in clearing E canis infection from the blood and tissues of dogs requires additional evaluation. HYPOTHESIS: Doxycycline (5 mg/kg PO q12h), administered for 4 weeks, will eliminate E canis infection from the blood and tissues of experimentally infected dogs. ANIMALS: Fifteen Walker hound-mixed breed dogs were inoculated subcutaneously with E canis-infected canine histiocytic cells 4 months before doxycycline treatment. METHODS: Four dogs were treated with doxycycline (5 mg/kg PO q12h for 3 weeks), 5 dogs were treated with doxycycline at the same dosage for 4 weeks, and 5 control dogs were not treated. Dexamethasone (0.4 mg/kg i.v.) was given after treatment to precipitate recrudescence of any remaining E canis organisms. Platelet counts, anti-E canis immunofluorescent antibodies, and polymerase chain reaction (PCR) detection of E canis deoxyribonucleic acid (DNA) in blood and tissues were evaluated. RESULTS: E canis DNA was not detected in the blood and tissues of doxycycline-treated dogs after treatment. Platelet counts were within reference intervals, and E canis antibodies decreased. Spontaneous clearance of E canis infection occurred in 2 of 5 control dogs. Three control dogs had E canis DNA detected in blood and tissues, platelet counts remained low or within the reference interval, and E canis antibodies remained high. CONCLUSIONS AND CLINICAL IMPORTANCE: As administered in this study, doxycycline cleared E canis from the blood and tissues of experimentally infected dogs.
BACKGROUND: Ineffective clearance of Ehrlichia canis after doxycycline administration has been reported despite the fact that the recommended treatment for canine ehrlichiosis is doxycycline. The effectiveness of doxycycline in clearing E canis infection from the blood and tissues of dogs requires additional evaluation. HYPOTHESIS: Doxycycline (5 mg/kg PO q12h), administered for 4 weeks, will eliminate E canis infection from the blood and tissues of experimentally infected dogs. ANIMALS: Fifteen Walker hound-mixed breed dogs were inoculated subcutaneously with E canis-infected canine histiocytic cells 4 months before doxycycline treatment. METHODS: Four dogs were treated with doxycycline (5 mg/kg PO q12h for 3 weeks), 5 dogs were treated with doxycycline at the same dosage for 4 weeks, and 5 control dogs were not treated. Dexamethasone (0.4 mg/kg i.v.) was given after treatment to precipitate recrudescence of any remaining E canis organisms. Platelet counts, anti-E canis immunofluorescent antibodies, and polymerase chain reaction (PCR) detection of E canis deoxyribonucleic acid (DNA) in blood and tissues were evaluated. RESULTS: E canis DNA was not detected in the blood and tissues of doxycycline-treated dogs after treatment. Platelet counts were within reference intervals, and E canis antibodies decreased. Spontaneous clearance of E canis infection occurred in 2 of 5 control dogs. Three control dogs had E canis DNA detected in blood and tissues, platelet counts remained low or within the reference interval, and E canis antibodies remained high. CONCLUSIONS AND CLINICAL IMPORTANCE: As administered in this study, doxycycline cleared E canis from the blood and tissues of experimentally infected dogs.
Authors: Jennifer C McClure; Michelle L Crothers; John J Schaefer; Patrick D Stanley; Glen R Needham; S A Ewing; Roger W Stich Journal: Antimicrob Agents Chemother Date: 2010-10-04 Impact factor: 5.191
Authors: Cruz M Arraga-Alvarado; Barbara A Qurollo; Omaira C Parra; Maribel A Berrueta; Barbara C Hegarty; Edward B Breitschwerdt Journal: Am J Trop Med Hyg Date: 2014-09-29 Impact factor: 2.345
Authors: M Lanza-Perea; U Zieger; B A Qurollo; B C Hegarty; E L Pultorak; S Kumthekar; R Bruhl-Day; E B Breitschwerdt Journal: J Vet Intern Med Date: 2014-10-01 Impact factor: 3.333
Authors: Domenico Otranto; Gabriella Testini; Filipe Dantas-Torres; Maria S Latrofa; Pedro Paulo Vissotto de Paiva Diniz; Donato de Caprariis; Riccardo P Lia; Norbert Mencke; Dorothee Stanneck; Gioia Capelli; Edward B Breitschwerdt Journal: J Clin Microbiol Date: 2010-07-21 Impact factor: 5.948
Authors: Patrick J Kelly; Chuanling Xu; Helene Lucas; Amanda Loftis; Jamie Abete; Frank Zeoli; Audrey Stevens; Kirsten Jaegersen; Kate Ackerson; April Gessner; Bernhard Kaltenboeck; Chengming Wang Journal: PLoS One Date: 2013-01-15 Impact factor: 3.240